Applied Therapeutics
Focus: Applied Therapeutics is a small-molecule biotech focused on rare and specialty diseases across oncology, infectious diseases, and neurology. The company operates from New York with a pipeline of Phase 2/3 programs but currently has zero revenue.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Open Jobs
236+237 this month
Hot — 249 jobs added in 30d
Net +237 (249 new, 12 removed). Aggressive expansion phase.
Should You Work at Applied Therapeutics?
AI assessmentApplied Therapeutics offers meaningful early-stage biotech exposure with near-term clinical catalysts, but current hiring freeze and pre-revenue status require diligence on funding and trial momentum.
Why Work Here
- Three Phase 3 programs (AT-007, Govorestat, AT-001) provide near-term catalysts and clinical advancement opportunities for research and development professionals
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Favipiravir
COVID-19Clinical Trials (1)
NCT04448119Control of COVID-19 Outbreaks in Long Term Care
Phase 2Help build intelligence for Applied Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.